{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:27:29Z","timestamp":1786991249086,"version":"build-2736575974"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.jad.2018.07.077","type":"journal-article","created":{"date-parts":[[2018,7,30]],"date-time":"2018-07-30T12:35:57Z","timestamp":1532954157000},"page":"86-93","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"special_numbering":"C","title":["Characterizing the course of suicidal ideation response to ketamine"],"prefix":"10.1016","volume":"241","author":[{"given":"Elizabeth D.","family":"Ballard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia S.","family":"Yarrington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristan A.","family":"Farmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Richards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"Machado-Vieira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bashkim","family":"Kadriu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5612-3021","authenticated-orcid":false,"given":"Mark J.","family":"Niciu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peixiong","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Carlos A.","family":"Zarate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2018.07.077_bib0001","series-title":"Version 21.0","year":"2016"},{"key":"10.1016\/j.jad.2018.07.077_bib0002","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jad.2018.01.027","article-title":"Parsing the heterogeneity of depression: an exploratory factor analysis across commonly used depression rating scales","volume":"231","author":"Ballard","year":"2018","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2018.07.077_bib0003","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.bbi.2014.07.012","article-title":"A role for inflammatory metabolites as modulators of the glutamate N-methyl-d-aspartate receptor in depression and suicidality","volume":"43","author":"Bay-Richter","year":"2015","journal-title":"Brain Behav. Immun"},{"key":"10.1016\/j.jad.2018.07.077_bib0004","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1037\/0022-006X.47.2.343","article-title":"Assessment of suicidal intention: the scale for suicide ideation","volume":"47","author":"Beck","year":"1979","journal-title":"J. Consult. Clin. Psychol."},{"key":"10.1016\/j.jad.2018.07.077_bib0005","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1176\/ajp.151.8.1132","article-title":"Initial reliability and validity of a new retrospective measure of child abuse and neglect","volume":"151","author":"Bernstein","year":"1994","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2018.07.077_bib0006","doi-asserted-by":"crossref","first-page":"9872","DOI":"10.1074\/jbc.M116.720029","article-title":"Brain-derived neurotrophic factor in megakaryocytes","volume":"291","author":"Chac\u00f3n-Fern\u00e1ndez","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jad.2018.07.077_bib0007","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1176\/appi.ajp.162.10.1805","article-title":"Lithium in the prevention of suicidal behavior and all-cause mortality in patients with mood disorders: a systematic review of randomized trials","volume":"162","author":"Cipriani","year":"2005","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2018.07.077_bib0008","series-title":"Increase in Suicide in the United States, 1999-2014. NCHS Data Brief No. 241","author":"Curtin","year":"2016"},{"key":"10.1016\/j.jad.2018.07.077_bib0009","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.4088\/JCP.09m05327blu","article-title":"Rapid resolution of suicidal ideation after a single infusion of an N-methyl-d-aspartate antagonist in patients with treatment-resistant major depressive disorder","volume":"71","author":"DiazGranados","year":"2010","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2018.07.077_bib0010","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1001\/archgenpsychiatry.2010.90","article-title":"A randomized add-on trial of an N-methyl-d-aspartate antagonist in treatment-resistant bipolar depression","volume":"67","author":"Diazgranados","year":"2010","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2018.07.077_bib0011","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/nm.4246","article-title":"Resting-state connectivity biomarkers define neurophysiological subtypes of depression","volume":"23","author":"Drysdale","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.jad.2018.07.077_bib0012","doi-asserted-by":"crossref","first-page":"e11089","DOI":"10.1371\/journal.pone.0011089","article-title":"Serum S100B: a potential biomarker for suicidality in adolescents?","volume":"5","author":"Falcone","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jad.2018.07.077_bib0013","article-title":"Structured clinical interview for DSM-IV-TR Axis I disorders, research version, non-patient edition (SCID-I\/NP)","author":"First","year":"2002","journal-title":"Biom. Res."},{"key":"10.1016\/j.jad.2018.07.077_bib0014","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1037\/bul0000084","article-title":"Risk factors for suicidal thoughts and behaviors: A meta-analysis of 50 years of research","volume":"143","author":"Franklin","year":"2017","journal-title":"Psychol. Bull."},{"key":"10.1016\/j.jad.2018.07.077_bib0015","doi-asserted-by":"crossref","first-page":"S195","DOI":"10.1016\/j.amepre.2014.06.012","article-title":"Existing and novel biological therapeutics in suicide prevention","volume":"47","author":"Griffiths","year":"2014","journal-title":"Am. J. Prev. Med."},{"key":"10.1016\/j.jad.2018.07.077_bib0016","series-title":"Proceedings of the ACNP Fifty Sixth Annual Meeting","article-title":"Ketamine for rapid relief of suicidal thoughts in depression: cognition and biomarkers in a midazolam-controlled trial","author":"Grunebaum","year":"2017"},{"key":"10.1016\/j.jad.2018.07.077_bib0017","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/bdi.12487","article-title":"Ketamine versus midazolam in bipolar depression with suicidal thoughts: a pilot midazolam-controlled randomized clinical trial","volume":"19","author":"Grunebaum","year":"2017","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2018.07.077_bib0018","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1176\/appi.ajp.2017.17060647","article-title":"Ketamine for rapid reduction of suicidal thoughts in major depression: a midazolam-controlled randomized clinical trial","volume":"175","author":"Grunebaum","year":"2018","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2018.07.077_bib0019","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1017\/S1461145713001119","article-title":"Plasma brain derived neurotrophic factor (BDNF) and response to ketamine in treatment-resistant depression","volume":"17","author":"Haile","year":"2014","journal-title":"Int. J. Neuropsychopharmacol"},{"key":"10.1016\/j.jad.2018.07.077_bib0020","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1038\/npp.2011.338","article-title":"Course of improvement in depressive symptoms to a single intravenous infusion of ketamine vs. add-on riluzole: results from a 4-week, double-blind, placebo-controlled study","volume":"37","author":"Ibrahim","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jad.2018.07.077_bib0021","series-title":"Proceedings of the ACNP Fifty Sixth Annual Meeting","article-title":"A randomized, double blind, placebo controlled trial of repeat-dose ketamine augmentation for chronic suicidal thinking","author":"Ionescu","year":"2017"},{"key":"10.1016\/j.jad.2018.07.077_bib0022","doi-asserted-by":"crossref","first-page":"468","DOI":"10.3109\/15622975.2011.624549","article-title":"Low plasma vascular endothelial growth factor (VEGF) associated with completed suicide","volume":"13","author":"Isung","year":"2012","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2018.07.077_bib0023","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1038\/sj.npp.1300252","article-title":"Altered NMDA glutamate receptor antagonist response in recovering ethanol-dependent patients","volume":"28","author":"Krystal","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jad.2018.07.077_bib0024","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.4088\/JCP.08m04659","article-title":"Brain-derived neurotrophic factor and initial antidepressant response to an N-methyl-d-aspartate antagonist","volume":"70","author":"Machado-Vieira","year":"2009","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2018.07.077_bib0025","article-title":"Latent class analysis and finite mixture modeling","volume":"2","author":"Masyn","year":"2013"},{"key":"10.1016\/j.jad.2018.07.077_bib0026","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2165\/11599770-000000000-00000","article-title":"Ketamine for treatment-resistant unipolar depression: current evidence","volume":"26","author":"Mathew","year":"2012","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jad.2018.07.077_bib0027","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1017\/S0033291715001506","article-title":"Ketamine for rapid reduction of suicidal ideation: a randomized controlled trial","volume":"45","author":"Murrough","year":"2015","journal-title":"Psychol. Med."},{"key":"10.1016\/j.jad.2018.07.077_bib0028","series-title":"Mplus Version 7 User's Guide","author":"Muthen","year":"2012"},{"key":"10.1016\/j.jad.2018.07.077_bib0029","series-title":"U.S. National Suicide Prevention Research Efforts: 2008\u20132013 Portfolio Analyses","year":"2015"},{"key":"10.1016\/j.jad.2018.07.077_bib0030","doi-asserted-by":"crossref","first-page":"e417","DOI":"10.4088\/JCP.13m08698","article-title":"Clinical predictors of ketamine response in treatment-resistant major depression","volume":"75","author":"Niciu","year":"2014","journal-title":"J. Clin. Psychiatry"},{"issue":"Suppl 16","key":"10.1016\/j.jad.2018.07.077_bib0031","first-page":"5","article-title":"Definitions of antidepressant treatment response, remission, nonresponse, partial response, and other relevant outcomes: a focus on treatment-resistant depression","volume":"62","author":"Nierenberg","year":"2001","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2018.07.077_bib0032","article-title":"Ketamine has distinct electrophysiological and behavioral effects in depressed and healthy subjects","author":"Nugent","year":"2018","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.jad.2018.07.077_bib0033","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jpsychires.2016.09.025","article-title":"Change in cytokine levels is not associated with rapid antidepressant response to ketamine in treatment-resistant depression","volume":"84","author":"Park","year":"2017","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jad.2018.07.077_bib0034","doi-asserted-by":"crossref","first-page":"35","DOI":"10.12740\/PP\/21175","article-title":"Factors connected with efficacy of single ketamine infusion in bipolar depression","volume":"48","author":"Permoda-Osip","year":"2014","journal-title":"Psychiatr. Pol."},{"key":"10.1016\/j.jad.2018.07.077_bib0035","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.biopsych.2009.04.029","article-title":"Effects of intravenous ketamine on explicit and implicit measures of suicidality in treatment-resistant depression","volume":"66","author":"Price","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2018.07.077_bib0036","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1001\/jamapsychiatry.2017.0080","article-title":"A consensus statement on the use of ketamine in the treatment of mood disorders","volume":"74","author":"Sanacora","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jad.2018.07.077_bib0037","doi-asserted-by":"crossref","first-page":"440","DOI":"10.2174\/1871527316666170413110605","article-title":"Abnormalities in kynurenine pathway metabolism in treatment-resistant depression and suicidality: a systematic review","volume":"16","author":"Serafini","year":"2017","journal-title":"CNS Neurol. Disord. Drug. Targets"},{"key":"10.1016\/j.jad.2018.07.077_bib0038","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1016\/j.euroneuro.2013.06.002","article-title":"The role of inflammatory cytokines in suicidal behavior: a systematic review","volume":"23","author":"Serafini","year":"2013","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2018.07.077_bib0039","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.4088\/JCP.15m10440","article-title":"Antisuicidal response following ketamine infusion is associated with decreased nighttime wakefulness in major depressive disorder and bipolar disorder","volume":"78","author":"Vande Voort","year":"2017","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2018.07.077_bib0040","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1176\/appi.ajp.2017.17040472","article-title":"The effect of a single dose of intravenous ketamine on suicidal ideation: a systematic review and individual participant data meta-analysis","volume":"175","author":"Wilkinson","year":"2017","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2018.07.077_bib0041","series-title":"Preventing Suicide: A Global Imperative","year":"2014"},{"key":"10.1016\/j.jad.2018.07.077_bib0042","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.biopsych.2011.12.010","article-title":"Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial","volume":"71","author":"Zarate","year":"2012","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2018.07.077_bib0043","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","article-title":"A randomized trial of an N-methyl-d-aspartate antagonist in treatment-resistant major depression","volume":"63","author":"Zarate","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2018.07.077_bib0044","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1038\/mp.2013.87","article-title":"Ketamine: synaptogenesis, immunomodulation and glycogen synthase kinase-3 as underlying mechanisms of its antidepressant properties","volume":"18","author":"Zunszain","year":"2013","journal-title":"Mol. Psychiatry"}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032718312205?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032718312205?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T01:19:37Z","timestamp":1759022377000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032718312205"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":44,"alternative-id":["S0165032718312205"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2018.07.077","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterizing the course of suicidal ideation response to ketamine","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2018.07.077","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}